Quinine
- TRADE NAMES: Adaquin; Chinine; Formula-Q; Genin; M-KYA; Q-Vel; Qualaquin (URL Pharma); Quinoctal; Quinsan; Quinsul; Quiphile
- INDICATIONS: Malaria
- CLASS: Antimalarial, Antiprotozoal
- HALF-LIFE: 8–14 hours
Amantadine, Amiodarone, Amitriptyline, Amoxapine, Anisindione, Anticoagulants, Arsenic, Artemether/Lumefantrine, Astemizole, Atazanavir, Atorvastatin, Cimetidine, Cisapride, Citalopram, Class Ia or III antiarrhythmics, Clevidipine, CYP3A4 and CYP2D6 substrates, CYP3A4 inducers or inhibitors, Darunavir, Dasatinib, Degarelix, Dicumarol, Digoxin, Disopyramide, Dofetilide, Dolasetron, Droperidol, Enalapril, Flecainide, Fosamprenavir, Halofantrine, Haloperidol, Histamine, Indinavir, Lapatinib, Levofloxacin, Mefloquine, Metformin, Moxifloxacin, Nelfinavir, Neuromuscular blocking agents, Olmesartan, Oral typhoid vaccine, Pazopanib, Pimozide, Procainamide, Prochlorperazine, Quinapril, Quinidine, Ramipril, Rifampin, Ritonavir, Saquinavir, Sotalol, Succinylcholine, Telavancin, Telithromycin, Terfenadine, Tipranavir, Voriconazole, Vorinostat, Warfarin, Ziprasidone
PREGNANCY CATEGORY: C
Qualaquin (quinine sulfate) is not idicated for the prevention or treatment of nocturnal leg cramps.
Contra-indicated in patients with prolongation of QT interval, G6PD deficiency, myasthenia gravis, or optic neuritis.
Please login to see the rest of this drug profile
Page last updated 08/02/2021
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
